Literature DB >> 18986439

Human mesenchymal stem cells may be involved in keloid pathogenesis.

Kozo Akino1, Sadanori Akita, Aya Yakabe, Takao Mineda, Tomayoshi Hayashi, Akiyoshi Hirano.   

Abstract

BACKGROUND: The pathogenesis of keloid is poorly understood. Although vigorous investigations have attempted to elucidate the mechanisms or causative factors of keloid, there are little data on why keloids are very intractable and recur easily in each patient.
METHODS: In an attempt to analyze the possible interaction between human mesenchymal stem cells and keloid-derived fibroblasts, the dual-chamber cell-migration assay, cell proliferation, ultrastructural morphology, and Western blot analysis were used to investigate the production of the extracellular matrices of the coculture.
RESULTS: Cell proliferation was not significantly different between keloid-derived fibroblasts and normal dermal fibroblasts during a 4-day observation period. There was a significant cell migration of human mesenchymal stem cells when keloid-derived fibroblasts were placed in the bottom chamber, compared to when normal dermal fibroblasts were placed in the same way in 8-microm diameter pore membranes (190.6 +/- 51.45 and 32.0 +/- 6.20 cells/field, respectively, P < 0.01). With 3-microm diameter pores, the human mesenchymal stem cells migrated in the pores only when the keloid-derived fibroblasts were placed in the bottom chambers (6.4 +/- 3.84 cells/field). Monolayer coculture of human mesenchymal stem cells and keloid-derived fibroblasts demonstrated further functional differentiation, such as collagen secretion and abundant rough endoplasmic reticulum. Western blot analysis of the cells in the modified dual-chamber culture demonstrated most significantly abundant fibronectin expression when the human mesenchymal stem cells contained keloid fibroblasts.
CONCLUSION: The results of this study may indicate that human mesenchymal stem cells participate and recruit in keloid pathogenesis by differentiating themselves toward keloid recalcitrant formation and progression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18986439     DOI: 10.1111/j.1365-4632.2008.03380.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  10 in total

Review 1.  Cell therapy of burns.

Authors:  T Leclerc; C Thepenier; P Jault; E Bey; J Peltzer; M Trouillas; P Duhamel; L Bargues; M Prat; M Bonderriter; J-J Lataillade
Journal:  Cell Prolif       Date:  2011-04       Impact factor: 6.831

Review 2.  Scaffolds and cells for tissue regeneration: different scaffold pore sizes-different cell effects.

Authors:  Ieva Bružauskaitė; Daiva Bironaitė; Edvardas Bagdonas; Eiva Bernotienė
Journal:  Cytotechnology       Date:  2015-06-20       Impact factor: 2.058

3.  Mesenchymal stromal cell mutations and wound healing contribute to the etiology of desmoid tumors.

Authors:  Adelaide M Carothers; Hira Rizvi; Rian M Hasson; Yvonne I Heit; Jennifer S Davids; Monica M Bertagnolli; Nancy L Cho
Journal:  Cancer Res       Date:  2011-11-17       Impact factor: 12.701

4.  Effect of human Wharton's jelly mesenchymal stem cell paracrine signaling on keloid fibroblasts.

Authors:  Anna I Arno; Saeid Amini-Nik; Patrick H Blit; Mohammed Al-Shehab; Cassandra Belo; Elaine Herer; Marc G Jeschke
Journal:  Stem Cells Transl Med       Date:  2014-01-16       Impact factor: 6.940

5.  Telomere dynamics in keloids.

Authors:  Mark Granick; Masayuki Kimura; Soyeon Kim; Lily Daniali; Xiaojian Cao; Utz Herbig; Abraham Aviv
Journal:  Eplasty       Date:  2011-03-16

Review 6.  The Keloid Disorder: Heterogeneity, Histopathology, Mechanisms and Models.

Authors:  Grace C Limandjaja; Frank B Niessen; Rik J Scheper; Susan Gibbs
Journal:  Front Cell Dev Biol       Date:  2020-05-26

7.  Keloid pathophysiology: fibroblast or inflammatory disorders?

Authors:  Ferdinand W Nangole; George W Agak
Journal:  JPRAS Open       Date:  2019-11-05

Review 8.  An Update on the Potential of Mesenchymal Stem Cell Therapy for Cutaneous Diseases.

Authors:  Yanyun Li; Ziyu Ye; Weiqin Yang; Qunzhou Zhang; Jincheng Zeng
Journal:  Stem Cells Int       Date:  2021-01-05       Impact factor: 5.443

9.  Tumor-like stem cells derived from human keloid are governed by the inflammatory niche driven by IL-17/IL-6 axis.

Authors:  Qunzhou Zhang; Takayoshi Yamaza; A Paul Kelly; Shihong Shi; Songlin Wang; Jimmy Brown; Lina Wang; Samuel W French; Songtao Shi; Anh D Le
Journal:  PLoS One       Date:  2009-11-11       Impact factor: 3.240

10.  Keloids and hypertrophic scars: update and future directions.

Authors:  Chenyu Huang; George F Murphy; Satoshi Akaishi; Rei Ogawa
Journal:  Plast Reconstr Surg Glob Open       Date:  2013-08-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.